超声新技术预测甲状腺乳头状癌颈部淋巴结转移的研究现状与展望
Research Status and Prospect of New Ultrasound Technology in Predicting Cervical Lymph Node Metastasis of Thyroid Papillary Carcinoma
查看参考文献35篇
|
文摘
|
甲状腺乳头状癌(PTC)是甲状腺癌所有病理类型中最常见的,占比高达90%,多为惰性肿瘤,但仍有少数具有侵袭性,颈部淋巴结转移(LNM)就是其侵袭性的重要表现之一。术前准确预测颈部LNM的情况,对治疗方案的选择和预后评估有着重要的意义。超声新技术是一种无创、便捷、无辐射的检查方式,对于预测PTC的颈部LNM有着重要的作用。本文就超声新技术预测PTC颈部LNM的研究现状进行相关综述和展望。 |
|
其他语种文摘
|
Papillary thyroid carcinoma (PTC) is the most common pathological type of thyroid cancer, accounting for 90%. Most cases of PTC are inert tumors,while a few are invasive. Cervical lymph node metastasis is one of the major manifestations of invasive PTC. Preoperative accurate prediction of cervical lymph node metastasis is of great significance for the selection of therapeutic regimen and the evaluation of prognosis. New ultrasound technology is a non-invasive,convenient,and radiation-free examination method,playing a key role in predicting the cervical lymph node metastasis of PTC. This paper reviews the research status and makes an outlook on new ultrasound technology in predicting cervical lymph node metastasis of PTC. |
|
来源
|
中国医学科学院学报
,2023,45(4):672-676 【核心库】
|
|
DOI
|
10.3881/j.issn.1000-503X.15073
|
|
关键词
|
超声新技术
;
甲状腺乳头状癌
;
预测
;
淋巴结转移
|
|
地址
|
中国人民解放军总医院第一医学中心超声诊断科, 北京, 100853
|
|
语种
|
中文 |
|
文献类型
|
综述型 |
|
ISSN
|
1000-503X |
|
学科
|
临床医学;肿瘤学 |
|
基金
|
北京市科学技术委员会AI +健康协同创新培育
|
|
文献收藏号
|
CSCD:7551658
|
参考文献 共
35
共2页
|
|
1.
Siegel R L. Cancer statistics,2020.
CA Cancer J Clin,2020,70(1):7-30
|
CSCD被引
4749
次
|
|
|
|
|
2.
Zhao L. Features and trends of thyroid cancer in patients with thyroidectomies in Beijing,China between 1994 and 2015: a retrospective study.
BMJ Open,2019,9(1):e023334
|
CSCD被引
1
次
|
|
|
|
|
3.
So Y K. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
Surgery,2010,148(3):526-531
|
CSCD被引
19
次
|
|
|
|
|
4.
Liu W. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: a single-center retrospective analysis of 3273 cases.
Medicine (Baltimore),2017,96(43):e8365
|
CSCD被引
7
次
|
|
|
|
|
5.
Zhao Q. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.
Ann Surg Oncol,2013,20(3):746-752
|
CSCD被引
28
次
|
|
|
|
|
6.
Oler G. Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.
Clin Cancer Res,2008,14(15):4735-4742
|
CSCD被引
3
次
|
|
|
|
|
7.
Aydin O U. The risk of hypoparathyroidism after central compartment lymph node dissection in the surgical treatment of pT1,N0 thyroid papillary carcinoma.
Eur Rev Med Pharmacol Sci,2016,20(9):1781-1787
|
CSCD被引
2
次
|
|
|
|
|
8.
Xu S Y. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion.
Head Neck,2019,41(11):3984-3991
|
CSCD被引
7
次
|
|
|
|
|
9.
L Jianming. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: significant role of HBME-1.
Eur J Radiol,2020,123:108801
|
CSCD被引
1
次
|
|
|
|
|
10.
Zhan J. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC)-Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy.
Clin Hemorheol Microcirc,2019,72(1):61-73
|
CSCD被引
2
次
|
|
|
|
|
11.
Wu Q. Clinical and sonographic assessment of cervical lymph node metastasis in papillary thyroid carcinoma.
J Huazhong Univ Sci Technolog Med Sci,2016,36(6):823-827
|
CSCD被引
2
次
|
|
|
|
|
12.
Gao X. Predictors and a prediction model for central cervical lymph node metastasis in papillary thyroid carcinoma (cN0).
Front Endocrinol (Lausanne),2021,12:789310
|
CSCD被引
3
次
|
|
|
|
|
13.
Tian X. Papillary thyroid carcinoma: an ultrasound-based nomogram improves the prediction of lymph node metastases in the central compartment.
Eur Radiol,2020,30(11):5881-5893
|
CSCD被引
8
次
|
|
|
|
|
14.
Jang J Y. Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma.
Head Neck,2019,41(8):2602-2609
|
CSCD被引
2
次
|
|
|
|
|
15.
Tu D G. Promotion of metastasis of thyroid cancer cells via NRP-2-mediated induction.
Oncol Lett,2016,12(5):4224-4230
|
CSCD被引
1
次
|
|
|
|
|
16.
Guang Y. Clinical study of ultrasonographic risk factors for central lymph node metastasis of papillary thyroid carcinoma.
Front Endocrinol (Lausanne),2021,12:791970
|
CSCD被引
2
次
|
|
|
|
|
17.
Xue T. Analysis of the relevance of the ultrasonographic features of papillary thyroid carcinoma and cervical lymph node metastasis on conventional andcontrastenhanced ultrasonography.
Front Oncol,2021,11:794399
|
CSCD被引
5
次
|
|
|
|
|
18.
Wang Y. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study of 8668 patients.
Int J Surg,2018,55:98-102
|
CSCD被引
9
次
|
|
|
|
|
19.
Sun J. Nomogram for preoperative estimation of cervical lymph node metastasis risk in papillary thyroid microcarcinoma.
Front Endocrinol (Lausanne),2021,12:613974
|
CSCD被引
4
次
|
|
|
|
|
20.
Zhan J. Application of contrast-enhanced ultrasound for evaluation of thyroid nodules.
Ultrasonography,2018,37(4):288-297
|
CSCD被引
7
次
|
|
|
|
|
了解气象卫星更多信息，请访问